HomeCompareALZCF vs EQR

ALZCF vs EQR: Dividend Comparison 2026

ALZCF yields 1.16% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALZCF wins by $7.52M in total portfolio value· pulled ahead in Year 5
10 years
ALZCF
ALZCF
● Live price
1.16%
Share price
$182.02
Annual div
$2.11
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.57M
Annual income
$6,495,363.68
Full ALZCF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — ALZCF vs EQR

📍 ALZCF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALZCFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALZCF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALZCF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALZCF
Annual income on $10K today (after 15% tax)
$98.53/yr
After 10yr DRIP, annual income (after tax)
$5,521,059.13/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, ALZCF beats the other by $5,516,404.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALZCF + EQR for your $10,000?

ALZCF: 50%EQR: 50%
100% EQR50/50100% ALZCF
Portfolio after 10yr
$3.81M
Annual income
$3,250,419.64/yr
Blended yield
85.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ALZCF
No analyst data
Altman Z
4.9
Piotroski
7/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALZCF buys
0
EQR buys
0
No recent congressional trades found for ALZCF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALZCFEQR
Forward yield1.16%5.87%
Annual dividend / share$2.11$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.8%
Portfolio after 10y$7.57M$47.8K
Annual income after 10y$6,495,363.68$5,475.61
Total dividends collected$7.46M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ALZCF vs EQR ($10,000, DRIP)

YearALZCF PortfolioALZCF Income/yrEQR PortfolioEQR Income/yrGap
1$10,932$231.84$11,380$679.82$448.00EQR
2$12,171$473.72$13,014$837.25$843.00EQR
3$14,009$985.81$14,961$1,036.20$952.00EQR
4$17,110$2,120.87$17,297$1,289.22$187.00EQR
5← crossover$23,150$4,841.93$20,121$1,613.15+$3.0KALZCF
6$37,015$12,245.00$23,561$2,030.84+$13.5KALZCF
7$76,203$36,596.51$27,783$2,573.54+$48.4KALZCF
8$222,361$140,824.10$33,013$3,284.39+$189.3KALZCF
9$1,006,015$768,088.75$39,547$4,223.51+$966.5KALZCF
10$7,571,800$6,495,363.68$47,791$5,475.61+$7.52MALZCF

ALZCF vs EQR: Complete Analysis 2026

ALZCFStock

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.

Full ALZCF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ALZCF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALZCF vs SCHDALZCF vs JEPIALZCF vs OALZCF vs KOALZCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.